Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

OBJECTIVES: The multinational PEARLS (ACTG A5175) study, conducted mainly in resource-limited settings, identified an increased treatment failure rate among HIV-infected individuals randomized to once-daily unboosted atazanavir, didanosine-EC, and emtricitabine compared with efavirenz-based regimens...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Antimicrob Chemother
Auteurs principaux: Castillo-Mancilla, Jose R., Aquilante, Christina L., Wempe, Michael F., Smeaton, Laura M., Firnhaber, Cynthia, LaRosa, Alberto M., Kumarasamy, Nagalingeswaran, Andrade, Adriana, Baheti, Gautam, Fletcher, Courtney V., Campbell, Thomas B., Haas, David W., MaWhinney, Samantha, Anderson, Peter L.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867099/
https://ncbi.nlm.nih.gov/pubmed/26892777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires